Table 2 Summary of population and reported treatment coverage rates 2001–2014
From: Mapping and modelling the impact of mass drug adminstration on filariasis prevalence in Myanmar
Year | No. of regions | No. of districts | Total population covered | Population which ingested drugs | Reported Treatment coverage | |
|---|---|---|---|---|---|---|
Overall | Range among districts | |||||
2001 | 1 | 2 | 1 939 964 | 1 803 306 | 93 | - |
2002 | 2 | 10 | 8 634 179 | 7 474 094 | 95.7 | 93.2–98.5 |
2004 | 5 | 22 | 17 929 178 | 15 838 896 | 82.6 | 80.1–94.3 |
2005 | - | - | No MDA | No MDA | - | - |
2006 | 4 | 15 | 11 868 901 | 10 761 777 | 90.7 | 79.5–94.1 |
2007 | 5 | 22 | 20 000 250 | 18 397 240 | 91.9 | 83.4–93.9 |
2008 | - | - | No MDA | No MDA | - | - |
2009 | 5 | 19 | 17 702 845 | 15 790 286 | 89.2 | 85.5–96.4 |
2010 | 4 | 12 | 10 035 458 | 9 002 092 | 89.7 | 82.7–95.4 |
2011 | 5 | 19 | 1 7031 636 | 15 429 100 | 90.5 | 85.8–93.4 |
2012 | - | - | No MDA | No MDA | - | - |
2013 | 7 | 36 | 35 488 298 | 30 313 249 | 85.4 | 68.7–93.8 |
2014 | 7 | 37 | 36 407 716 | 31 121 035 | 85.5 | 74.8–93.7 |